Q/C Technologies (QCLS) Stock: Shkreli-Fueled Quantum-Class Rally, Latest News and Forecasts as of December 5, 2025

Q/C Technologies, Inc. (NASDAQ: QCLS) has suddenly gone from obscure microcap to social‑media star. Over just two trading sessions, the stock has effectively doubled after former pharma executive Martin Shkreli disclosed a position, floated a near‑term $100 price target, and hinted at wanting to run the company if regulators ever let him back into a C‑suite. ^[1]

Underneath the drama is a tiny company that recently pivoted from biotech into “quantum‑class” photonic computing and blockchain infrastructure, built around licensed light‑based processors from Israeli startup LightSolver. ^[2]

This article pulls together the latest news, price action, forecasts and analyses as of December 5, 2025, with an eye toward what matters if you’re trying to understand QCLS rather than just chase the ticker.

1. Where Q/C Technologies Stock Stands on December 5, 2025

Price and trading action

QCLS closed on December 4, 2025 at $6.92, up 48.18% on the day, with an intraday range from $5.40 to $7.95 and roughly 90–91 million shares traded. ^[3]
The day before (Dec 3), it closed at $4.67, up about 38% from a prior close around $3.38, with volume in the tens of millions. ^[4]
Various real‑time and forecast services show QCLS trading around $7 on December 5, implying a two‑day move of roughly 100%+ and a one‑month gain above 110–120%. ^[5]

Size and volatility

Market cap is in the $20–30 million range depending on which closing price you use, based on about 4.17 million shares outstanding. ^[6]
52‑week range: about $2.50 to $164 – the high is mostly a reverse‑split artifact plus some illiquid spikes, but it underscores just how wild this chart has been. ^[7]
Beta estimates around 2.0–2.3 and recent daily swings of 20–40%+ put QCLS firmly in “extremely high volatility” territory. ^[8]

In short: as of December 5, QCLS is tiny, hyper‑volatile, and suddenly heavily traded.

2. From Biotech to Quantum‑Class Computing and Blockchain

Until this year, Q/C Technologies was TNF Pharmaceuticals (TNFA), a clinical‑stage biotech working on inflammatory and age‑related diseases. In 2024 its auditor even raised a “going concern” doubt after a $23.4 million annual net loss. ^[9]

The pivot to “quantum‑class” tech unfolded in three big steps:

Exclusive LightSolver license (Sept 2, 2025)
- TNF announced an exclusive global license to use LightSolver’s laser‑based “Light Speed Computing Accelerator” (Laser Processing Units, or LPUs) for cryptocurrency and blockchain applications. ^[10]
- The technology is pitched as light‑ and laser‑based computing that can outperform both GPUs and quantum computers on certain optimization problems while cutting energy use by up to ~90% in crypto‑related workloads. ^[11]
Name and ticker change (Sept 24–25, 2025)
- The company changed its name from TNF Pharmaceuticals, Inc. to Q/C Technologies, Inc., and its ticker from TNFA to QCLS, explicitly “to reflect [its] strategic focus on quantum‑class photonic computing.” ^[12]
- QCLS began trading under the new symbol on Nasdaq on September 25, 2025. ^[13]
Qc‑LPU100 product line and quantum advisor (Oct 2025)
- On October 16, 2025, Q/C appointed Technion professor Dr. Steven Frankel as Senior Quantum Advisor to steer its photonic and quantum‑class computing initiatives. ^[14]
- On October 30, 2025, Q/C launched its own branded qc‑LPU100™ line of “quantum‑class laser processing units”, based on the LightSolver technology, aimed at achieving quantum‑class speeds using natural light instead of electrical signals and marketed as faster and more efficient than GPUs or quantum processing units (QPUs). ^[15]

Several data vendors now describe Q/C as a company building faster, more energy‑efficient blockchain infrastructure using laser‑based processors, highlighting its exclusive rights to LightSolver’s LPU tech for crypto and certain optimization tasks. ^[16]

So today’s “quantum‑class” microcap is basically yesterday’s struggling biotech, with a new high‑performance computing license and a marketing overhaul.

3. Inside the Shkreli‑Driven Rally

The latest fireworks really started this week.

Shkreli’s $100 “near‑term” target

On December 4, multiple outlets reported that Martin Shkreli posted on X (Twitter) that he had bought QCLS shares and set a “near‑term” price target of $100, citing Microsoft’s optical/photonic computing roadmap as part of his bull case. ^[17]

Stocktwits news summarized the move as a 60%+ intraday surge “after Shkreli said he had bought the stock” and floated the $100 target. ^[18]
Investing.com noted that QCLS rose 38% on Wednesday and another ~16% on Thursday, attributing the rally to Shkreli identifying Q/C as a long idea. ^[19]
Some coverage also reported Shkreli musing that he’d consider becoming CEO if a future Trump administration allowed it, which would require regulatory action because of his existing restrictions. ^[20]

Tech‑focused site TS2.Tech framed it as a microcap quantum/blockchain stock “doubling in two sessions” on the back of the Shkreli call, while warning about the mismatch between hype and fundamentals. TechStock²

Trading‑community hype

Day‑trading and penny‑stock communities have piled on:

StocksToTrade and Timothy Sykes’ sites ran multiple pieces on December 3–4 dissecting QCLS’s intraday momentum, emphasizing the massive volume spike, negative net income, and the importance of risk management in such setups. ^[21]
AInvest’s AI‑generated recap of the December 3 move highlighted a 38.5% rally with turnover up over 1,000%, driven by chatter about quantum‑computing patents and rumored partnerships, while explicitly flagging the speculative nature of those catalysts. ^[22]
Reddit penny‑stock threads now describe QCLS as a “hidden quantum penny play,” pointing to the qc‑LPU100 launch and the government’s interest in quantum companies, but also acknowledging dilution and the stock’s past life as a biotech. ^[23]

The short version: this is a classic low‑float, high‑story momentum move, now turbo‑charged by a polarizing celebrity investor.

4. Fundamentals After Q3 2025: Smaller Losses, Bigger Balance Sheet

Behind the meme‑y price action, Q/C’s latest numbers come from its Q3 2025 Form 10‑Q, filed November 19. ^[24]

Key points:

Q3 2025 (quarter ended Sept 30, 2025)
- Net loss of about $2.8 million, slightly wider than the ~$1.9 million loss a year earlier. ^[25]
- The company remains pre‑revenue in its new quantum/blockchain line; historic biotech programs also have not produced commercial revenue. ^[26]
Nine months ended Sept 30, 2025
- Net loss of about $5.73 million, a big improvement from $21.3 million in the same period of 2024 (helped in part by restructuring and non‑cash effects). ^[27]
- After preferred dividends, the loss attributable to common shareholders was around $8.4 million. ^[28]
Balance sheet and cash
- Total assets climbed to roughly $37.2 million from about $21.4 million, mainly because of a technology license (~$14.1M) and goodwill (~$10.5M) linked to the LPU acquisition and LightSolver licensing. ^[29]
- Cash of around $6.9 million and marketable securities of about $3.1 million as of Sept 30, 2025 give the company a modest cash cushion. ^[30]
- Working capital was reported around $4.6 million, suggesting some near‑term liquidity but not a fortress balance sheet. ^[31]
Capital structure
- Q/C has a complex mix of preferred stock series (F, F‑1, G, H, etc.), many convertible into common stock, plus an equity incentive plan that shareholders recently expanded by 1.375 million shares to a total of 1.4 million available for awards. ^[32]
- Common shares outstanding rose from about 3.0 million at Sept 30 to 4.17 million by mid‑November, reflecting conversions, preferred financings and stock‑based awards. ^[33]

In very plain language: losses are shrinking compared to the old biotech era, but Q/C is still burning cash, has no meaningful revenue yet, and is funding the pivot with dilution and preferred stock.

5. What Q/C Is Actually Building: qc‑LPU100 and “Quantum‑Class” Claims

The company’s story now revolves around LightSolver’s LPU technology and Q/C’s own qc‑LPU100™ units.

From company releases and partner write‑ups: ^[34]

Architecture
- LPUs use arrays of lasers and optical components to encode and solve certain classes of optimization and constraint‑satisfaction problems, leveraging interference patterns of light rather than transistor switching.
- The company markets these as “quantum‑class” rather than pure quantum computers: the physics is optical/analog, but the goal is to match or beat quantum hardware on speed and problem scale for specific workloads.
Performance and energy claims
- Marketing materials talk about orders‑of‑magnitude speed‑ups (up to ~100x vs state‑of‑the‑art GPUs or quantum systems) and up to ~90% lower energy consumption for cryptocurrency and blockchain workloads, though independent, peer‑reviewed benchmarks are not yet publicly available. ^[35]
Target markets
- Near term: crypto mining and blockchain infrastructure, where raw hash‑ or optimization‑throughput per watt is a big selling point.
- Longer term: general high‑performance computing (HPC), AI optimization, and financial or logistics problems that map well to Ising‑type or combinatorial formulations—similar use cases targeted by other analog/quantum‑inspired solvers.
Ecosystem signaling
- LightSolver has been recognized as a World Economic Forum Technology Pioneer and appears in Gartner’s Hype Cycle for data‑center infrastructure, which Q/C leans on to bolster the sense that it’s surfing a serious trend, not just marketing buzzwords. ^[36]

The gap between ambitious physics‑heavy marketing and actual deployed customers and recurring revenue, however, is still large. Investors effectively have to bet that Q/C can turn a license and some early‑stage hardware into a real infrastructure business before the balance sheet runs thin.

6. Technical Picture: Momentum, Volatility and Ratings

Different technical‑analysis shops all agree on at least one thing: QCLS is wild.

Recent surge
- From late November lows around $2.50–3.00, QCLS has run to about $7, with StockInvest.us calculating a 113% gain over the last two weeks and a 48% jump just on December 4. ^[37]
- TradingView notes that the one‑month gain exceeds 110%, even while the one‑year change is still deeply negative because of the pre‑pivot biotech collapse and a 1:100 reverse split. ^[38]
Moving averages and momentum indicators
- Tickeron flags QCLS’s MACD turning positive on November 18 and the price crossing above its 50‑day moving average on December 3, labeling the setup as a bullish momentum configuration based on historical patterns. ^[39]
- CoinCodex shows QCLS with 16 “green days” out of the last 30 and a 30‑day volatility above 18%, with their sentiment flag currently set to “Bullish”. ^[40]
Third‑party technical ratings
- ChartMill gives QCLS a technical rating of 4/10 (mid‑pack) but a fundamental rating of 1/10, emphasizing the speculative nature of the move and pointing out that the stock is up more than 120% over the past month. ^[41]
- StockInvest calls QCLS “very high risk”, pointing to daily swings near 50% and an RSI above 80, traditionally considered overbought. It currently labels the stock a “Hold/Accumulate” rather than an outright buy. ^[42]

In other words: the chart screams momentum trader playground, not “sleep‑at‑night core holding”.

7. Stock Forecasts and Price Targets: Algorithms vs Hype

There is no traditional Wall Street analyst coverage yet—no consensus earnings models, no 12‑month price targets from big banks. Simply Wall St explicitly notes that there isn’t enough coverage or history to model future earnings. ^[43]

Instead, you get three main flavors of “forecast”:

7.1. The Shkreli thesis: $100 “near‑term”

Shkreli’s call is the loudest:

He’s publicly disclosed buying QCLS and floated a $100 “near‑term” price target, implying more than 10x upside from the ~$7 range. ^[44]
The thesis leans on Microsoft’s work on optical/photonic computing, the scarcity of public “quantum‑class” plays, and Q/C’s tiny market cap relative to the perceived potential of its technology. ^[45]

That’s not a traditional equity‑research target; it’s a speculative, personality‑driven call, and markets are treating it accordingly.

7.2. Quant/website models: mildly bullish to sharply bearish

Various forecasting sites run purely statistical or technical models on QCLS, often arriving at very different conclusions:

CoinCodex
- 5‑day forecast around $6.8, 1‑month around $6.16 (an ~11% pullback), but a model that suggests ~25% upside by May 2026 from current levels in a scenario they illustrate. ^[46]
Gov.Capital / WalletInvestor‑style services
- One model shows a current price ~ $7.07 on Dec 5 but projects a 14‑day drop of ~50%+ and multi‑month downside of 60%+, with very negative 1‑year and 5‑year expectations. ^[47]
Macroaxis
- Triple‑exponential smoothing gives a next‑day forecast around $6.72, with relatively wide error bands—useful more as a measure of volatility than a real “target.” ^[48]

These systems are agnostic about the tech; they just chew on historical price/volume and sometimes basic fundamentals. Their disagreement is a good reminder that short‑term price forecasting for a microcap like this is mostly noise.

7.3. Technical/idea platforms

Some platforms wrap technical indicators and narrative around QCLS:

StockInvest.us treats QCLS as a “Hold/Accumulate” after its trend break, eyeing possible resistance near $7.4 and support zones in the mid‑$5 range. ^[49]
Tickeron highlights bullish momentum signals but essentially frames QCLS as a high‑risk momentum trade, not a long‑term compounding story. ^[50]
StocksToTrade / Tim Sykes articles stress that traders may find opportunity in the volatility but repeatedly warn readers not to confuse a hot chart with a solid long‑term investment without deep due diligence. ^[51]

The common theme: no one with a traditional fundamental model is blessing this as “cheap”, and the automated models are all over the place.

8. Key Risks and Issues for QCLS Investors

Strip away the buzzwords, and the risk checklist looks something like this:

Microcap + low float + huge volume = pump‑and‑dump risk
- With a market cap under $30M and just over 4M shares outstanding, any sudden wave of social‑media‑driven buying or selling can cause enormous swings, as this week demonstrates. ^[52]
Business model is early, unproven and capital‑hungry
- Q/C has no meaningful recurring revenue yet from its quantum‑class or blockchain offerings, but it does have R&D, SG&A, and hardware commercialization costs. ^[53]
- The 2024 “going concern” flag hasn’t magically disappeared; it’s just temporarily masked by new capital raises and intangible asset entries. ^[54]
Heavy dilution and complex preferred stack
- Multiple series of convertible preferred stock (including a large Series H issued in a $7M private placement) plus an expanded equity incentive pool mean future dilution is very likely if the company keeps funding growth with equity. ^[55]
Concentrated dependence on LightSolver and a niche tech
- Q/C’s new identity depends on a single licensed technology from one partner, in a field where other quantum/photonic players are both better funded and further along. Competitive, technical or legal issues around that license would be a big problem. ^[56]
Reputational and regulatory overhang from Shkreli involvement
- While a celebrity bull case can move the stock, it also introduces regulatory attention, short‑seller interest, and governance questions—especially if Shkreli continues to talk about future leadership roles that would require regulatory relief. ^[57]

None of these automatically doom the company, but together they underline that QCLS sits at the speculative end of the risk spectrum. This is not some sleepy dividend payer mispriced by 5%; it’s closer to a lottery ticket on photonic‑computing commercialization plus sentiment staying hot long enough to matter.

9. What to Watch Next for Q/C Technologies Stock

For people monitoring QCLS beyond this week’s fireworks, the most important catalysts over the next few quarters aren’t tweets—they’re evidence of execution:

Concrete qc‑LPU100 milestones: shipping units, real‑world benchmarks, and—most importantly—paying customers in crypto, AI, or HPC. ^[58]
Follow‑on disclosures from LightSolver: new funding, big‑name partners, or technical papers would indirectly help Q/C’s credibility as the exclusive blockchain/crypto licensee. ^[59]
Next filings and capital raises: the next 10‑Q and any 8‑Ks will show how fast Q/C is burning cash, how much new equity it’s issuing, and whether it’s signing real contracts versus just doing corporate engineering. ^[60]
Regulatory or listing developments: after the 1:100 reverse split and name change, any fresh listing‑compliance issues or reverse splits would be red flags. ^[61]

Final word

As of December 5, 2025, Q/C Technologies is a tiny, loss‑making, early‑stage quantum‑class computing hopeful whose stock has been catapulted higher by social‑media attention and a high‑profile speculative bull call. The underlying technology story is interesting and fits real trends in photonic and quantum‑inspired computing, but the gap between headline and revenue is still wide, and the risk of sharp reversals is obvious on the tape.